PMID: 15353869Sep 9, 2004Paper

Angiographic restenosis after myocardial bridge stenting

Japanese Heart Journal
Hurkan KursakliogluErsoy Isik

Abstract

Data on restenosis after stent implantation in myocardial bridges (MB) are very limited. Six-month angiographic results for 12 symptomatic patients who underwent stent implantation for myocardial bridges were compared retrospectively with those of 39 patients who underwent direct stent implantation for de novo atherosclerotic lesions in the left anterior descending artery. Diameter stenosis decreased from 69 +/- 8% to 4 +/- 5% in the MB group and from 79 +/- 8% to 7 +/- 6% in the control group after stent deployment. Systolic narrowing was abolished in all patients with MB. In follow-up, quantitative angiography revealed late loss of 1.8 +/- 1.3 mm in the MB group and 0.9 +/- 0.9 mm in the control group (P = 0.025). The in-stent restenosis rate was also higher in the MB group compared to the control group (67% versus 28%; P = 0.037). Despite favorable immediate results, stent implantation in MBs may not be promising because of the higher in-stent restenosis rate compared to stenting in de novo atherosclerotic lesions.

References

Jul 1, 1983·Progress in Cardiovascular Diseases·P AngeliniR D Leachman
Apr 1, 1981·The American Journal of Cardiology·A D PichardJ A Rodriguez
Aug 26, 1998·The Journal of Pathology·T IshiiY Ishikawa
Aug 28, 1999·Journal of Electrocardiology·J Ortega-Carnicer, V Fernández-Medina
Apr 30, 2002·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·John F BerryRichard A Kerensky
Nov 13, 2002·Circulation·Stefan MöhlenkampRaimund Erbel
Feb 11, 2003·Journal of the American College of Cardiology·Martial G BourassaJean-Claude Tardif

❮ Previous
Next ❯

Citations

Jul 7, 2011·Cardiology in the Young·Jayendra SharmaRalph Mosca
Aug 11, 2007·Theoretical Biology & Medical Modelling·Pierre-André DoriotJacques Noble
Apr 7, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Yukio IshikawaToshiharu Ishii
Sep 9, 2005·International Journal of Cardiovascular Interventions·Arkadiusz A Derkacz, Przemyslaw J Nowicki
Jan 13, 2015·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Hao LuJunbo Ge
Aug 30, 2008·International Journal of Cardiology·Cem BarcinBasri Amasyali
Mar 3, 2007·International Journal of Cardiology·Juan RondanCesar Moris
Mar 11, 2008·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Prabhakar B KunamneniAnnapoorna S Kini
Mar 11, 2008·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Anwar TandarAndrew D Michaels
Jul 14, 2011·Clinical Anatomy : Official Journal of the American Association of Clinical Anatomists & the British Association of Clinical Anatomists·Marios LoukasRobert H Anderson
May 23, 2012·Journal of Cardiac Surgery·Xiaoning SunChunsheng Wang
May 12, 2009·The American Journal of Cardiology·Kenichi TsujitaRoxana Mehran
Mar 4, 2014·Journal of the American College of Cardiology·Michel T CorbanHabib Samady
May 19, 2010·Clinical Nuclear Medicine·Antonios ZiakasG Parharidis
Aug 27, 2021·Journal of Cardiac Surgery·Zhonghua XuQibiao Quan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.